| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Business Innovation - Effective Team Structures |
|
E-Folder - Business Innovation - Effective Team Structures
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product selection, development and commercialisation. There are other useful definitions in this field, for example, cre ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in tivity can be defined as consisting of a number of ideas, a number of diverse ideas and a number of novel ideas. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. There are distinct processes that enhance problem identification and idea generation and, similarly, distinct pr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe cesses that enhance idea selection, development and commercialisation. Whilst there is no sure fire route to comm d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ercial success, these processes improve the probability that good ideas will be generated and selected and that i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc vestment in developing and commercialising those ideas will not be wasted. Effective Team Structures T easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi he fact that the sum of ideas produced by individuals working alone is greater than the number of ideas produced nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically y those individuals working in a group, is an indicator that team and groups structures are important considerati and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ons: a) Large teams benefit from intellectual cross-pollination, but factors such as groupthink, core and periph ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ral information channels, status interactions, social loafing and individual shut downs reduce overall performanc ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a . b) Pairs reduce intellectual cross pollination but some of the above inhibitors are also reduced. However, pai dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rs are very successful – many comedy partnerships and creative teams in advertising working pairs. c) Individual cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin are prone to path dependency, parochialism and competency traps. But many well known creations have been develop tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ed by individuals alone. So what is the most effective team structure? These and other topics are covered in de t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel th in the MBA dissertation on Managing Creativity & Innovation, which can be purchased (along with a Creativity a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nd Innovation DIY Audit, Good Idea Generator Software and Power Point Presentation) from y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products tp://www.managing-creativity.com/">http://www.managing-creativity.com/ You can also receive a regular, free . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de newsletter by entering your email address at this site. Kal Bishop, MBA ********************************** You elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip are free to reproduce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Reduce Medical Billing Time and Overhead Costs for Your Medical Practice Finding The Right Financing For Your Business Successful Telecommuting Mom Story Number 1
|